Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks, breaking the silence. Nice to see some revenue.
I’m not looking for the audit to be a catalyst. Im looking for the catalysts that can come with being audited. Partnering companies becoming more involved with us, financially or otherwise.
That was Abveris opening a new location, not Enzo. We are just collaborating with them.
https://www.abveris.com/blog/twist-bioscience-opens-new-twist-boston-location-to-expand-antibody-discovery-capacity
I agree with inside interest. They tweeted this yesterday after 2 months of silence.
https://twitter.com/corpemergent/status/1588163934732926977?s=46&t=E6Z5FaUEp5dbQ8VYuxjQlw
If I recall correctly, they said they were training a sales force and would be wrapping that up towards end of year.
Getting to be that time.
$FBEC
0.0001
Expert Market, AS: 7.0B, OS: 6.0B
Outstanding Shares Updated:
3,582,383,902 (2018-02-02)
6,035,000,794 (2022-10-24)
Difference: +68.5% (+2.5B)
Note: More than 3 years passed since the last update, the difference might not represent the business development correctly
Chart, OTC Profile, Twitter, @otcupdates
Update: 2022-10-26 13:00:02 (UTC)
Golden cross is a short term ma crossing above a long term ma.
50 day moving average crossing the 200 day in an uptrend.
Repeat toxicity study for ITV-1.
Samsung is involved only with mabs. IPF is not a mab, and Samsung was never involved with that side.
As far as veterinary mabs, Samsung did express a big interest in our entire mab pipeline. So it’s possible they’d want those as well.
That was in vitro, today’s news is using animal toxicology.
Will you love hearing about monoclonal antibodies at .25, .50, or .75?
I will, especially the ENZC kind.
Hoping for it.
Maybe you can elaborate on what you think is missing.
The day will come when we get a proper valuation, and I believe this patent alone will be worth far more than $1B.
Not sure what chick you’re talking about. I’m going off of the company website, news section. Legit enough for me.
“As to each of these entities and those with whom the Company currently works on an ongoing basis, the Company has entered into NDAs (Nondisclosure Agreements) necessary to preserve and protect the Company plans and intellectual property being discussed and exchanged between the parties. These contractual restrictions are critical for the Company and its partners.”
https://enzolytics.com/company-news/
I believe that is what is happening with the NDA’s. They’ve partnered with other, potentially bigger, companies to help get further on in the process.
We won’t know until NDA’s lift, but I’m certainly going to be here with my fun coupons when it happens.
Ever get a response?
Mix in reputable management.
Look at it however you want. I explained exactly what they’re trying to accomplish with this collaboration as I interpret it from the PR’s.
Typically traders, CEO’s, etc. pump in order to increase SP and sell into the pump/increase. They are not a dilutive company, there would be no reason to pump. Others have said they’re stealing holders money, I think the best opportunity for that would’ve been at .50-.95 which did not occur. Kinda kills that whole logic doesn’t it?
I look at this as an update on company actions/progress and I think it’s great.
So agree to disagree.
In reference to MAB’s already being produced.
On the last update they expressed interest in mucosal antibodies.
“There is a significant role for mucosal immunity and secretory as well as circulating IgA antibodies in COVID-19. Therefore, Enzolytics focus on mucosal immunity for COVID-19. Enzolytics firmly believe that mucosal immunity can be exploited for beneficial diagnostic, therapeutic, or prophylactic purposes.”
https://enzolytics.com/company-news/
Today’s PR states they are searching for mucosal antibodies with Abveris.
"To efficiently block COVID-19 infections and transmission, we need to get high levels of secretory IgA, reflecting mucosal immunity. Abveris will identify promising monoclonal antibody candidates via function-forward, high-resolution screening under expedited timelines”
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies
No, they are trying to get antibodies for mucosal immunity now as well. That’s been a recent topic with them.
"To efficiently block COVID-19 infections and transmission, we need to get high levels of secretory IgA, reflecting mucosal immunity. Abveris will identify promising monoclonal antibody candidates via function-forward, high-resolution screening under expedited timelines”
Tortilla!!!!!! Lol. He was the lonely original bear.
April 2020
Pink current.
Very probable with the new attention on Mabs currently. With the right patents we’ll own the gold mine.
Last acquisition should be closing any day now if I’m not mistaken. We should be ready for the next move with an update.
A good update should bring some volume to this little SS and make for a nice run.
So you must have spoken to Malone Bailey? I guess anyone could call and find out why they’re no longer engaged by us.
Quite the claim to make.
“Please be clear on one thing, the underlying reason Malone Baley CPA's is no longer engaged by ENZC is that the management of ENZC COULD NOT provide the information required by the auditors to issue a clean opinion on the financial statements for 2019 and 2020.”
Lol. No worries, we do know Harry isn’t the best business man.
Always good to think outside the box or from a different perspective, but I don’t think we need to worry about Savov.
We should all be good here hopefully sooner than later.
Would imagine anything he does know deals strictly with IPF which is currently patented. What would be your concern?
Getting thin down here. When this goes, it’s gonna go I think.
Truly believe it will. If some of my others pop off like I think they will, I’ll be able to buy a nice chunk here.
I see this brought up a lot. How are they making money?
Would be nice to see some adjustments to the SS in the future if possible.
Awesome, thanks.
Sooooo……about that good news. Anyone want to share?
Was hoping for that or negotiating to convert later.
Lol. Was thinking the same this morning.
Should be fun ride.
Daily chart should be turning back up here soon. That next interview may have some good info that will help out with some volume.